Database Analysis of Eplerenone Use in Japanese Hypertensive Patients in Clinical Practice

Database Analysis of Eplerenone Use in Japanese Hypertensive Patients in Clinical Practice

Eplerenone, a mineralocorticoid receptor antagonist (MRA), is available in Japan, but details of its use in clinical settings have not been thoroughly investigated. Thus, this study was aimed at examining the characteristics of eplerenone-prescribed hypertensive patients in Japan, describing the com...

Full description

Bibliographic Details
Main Authors:	Shoko Takahashi, Yoichi Ii, Yuji Yamamoto, Aya Ikeda, Yoko Fujimoto
Format:	Article
Language:	English
Published:	Hindawi Limited 2019-01-01
Series:	International Journal of Hypertension
Online Access:	http://dx.doi.org/10.1155/2019/3726419

Similar Items

New Clinical Aspects of Eplerenone Use in Clinical Practice
by: S. R. Gilyarevskiy, et al.
Published: (2018-09-01)

Efficacy of eplerenone added to renin-angiotensin blockade in elderly hypertensive patients: the Jichi-Eplerenone Treatment (JET) study
by: Yuichiro Yano, et al.
Published: (2011-09-01)

Eplerenone ethanol solvate
by: Duan-Jun Xu, et al.
Published: (2008-05-01)

Routine Clinical Practice Treatment Outcomes of Eplerenone in Acute and Chronic Central Serous Chorioretinopathy
by: Katrin Fasler, et al.
Published: (2021-05-01)

Safety and Antihypertensive Effect of Selara® (Eplerenone): Results from a Postmarketing Surveillance in Japan
by: Shoko Takahashi, et al.
Published: (2016-01-01)

EVIDENCE-BASED USE OF EPLERENONE
by: S. R. Gilyarevski, et al.
Published: (2014-07-01)

EVIDENCE-BASED USE OF EPLERENONE
by: S. R. Gilyarevski, et al.
Published: (2014-07-01)

A SELECTIVE ANTAGONIST OF MINERALOCORTICOID RECEPTOR EPLERENONE IN CARDIOLOGY PRACTICE
by: B. B. Gegenava, et al.
Published: (2015-09-01)

A SELECTIVE ANTAGONIST OF MINERALOCORTICOID RECEPTOR EPLERENONE IN CARDIOLOGY PRACTICE
by: B. B. Gegenava, et al.
Published: (2015-09-01)

Eplerenone in the Treatment of Polypoidal Choroidal Vasculopathy
by: Kapil G. Kapoor, et al.
Published: (2015-12-01)

Treatment procedures and associated medical costs of methicillin-resistant infection in Japan: A retrospective analysis using a database of Japanese employment-based health insurance
by: Akira Yuasa, et al.
Published: (2019-08-01)

Eplerenone-Resistant Salt-Sensitive Hypertension in Nedd4-2 C2 KO Mice
by: Tabito Kino, et al.
Published: (2017-06-01)

Eplerenone reduces arterial thrombosis in diabetic rats
by: Agnieszka Zakrzeska, et al.
Published: (2015-12-01)

Eplerenone attenuates pathological pulmonary vascular rather than right ventricular remodeling in pulmonary arterial hypertension
by: Mario Boehm, et al.
Published: (2018-03-01)

SAFETY AND EFFICACY OF EPLERENONE IN PATIENTS AT HIGH RISK FOR HYPERKALEMIA AND/OR WORSENING RENAL FUNCTION. ANALYSES OF THE EMPHASIS-HF STUDY SUBGROUPS (EPLERENONE IN MILD PATIENTS HOSPITALIZATION AND SURVIVAL STUDY IN HEART FAILURE)
by: R. Eschalier, et al.
Published: (2015-09-01)

SAFETY AND EFFICACY OF EPLERENONE IN PATIENTS AT HIGH RISK FOR HYPERKALEMIA AND/OR WORSENING RENAL FUNCTION. ANALYSES OF THE EMPHASIS-HF STUDY SUBGROUPS (EPLERENONE IN MILD PATIENTS HOSPITALIZATION AND SURVIVAL STUDY IN HEART FAILURE)
by: R. Eschalier, et al.
Published: (2015-09-01)

Oral eplerenone for the management of chronic central serous chorioretinopathy
by: Rishi P Singh, et al.
Published: (2015-04-01)

Eplerenone inhibits aldosterone-induced renal expression of cyclooxygenase
by: MA Bayorh, et al.
Published: (2012-09-01)

PHARMACOECONOMIC ASPECTS OF EPLERENONE USAGE IN CHRONIC HEART FAILURE
by: Yu. M. Lopatin, et al.
Published: (2015-08-01)

Eplerenone in the treatment of central serous chorioretinopathy: a review of the literature
by: Irini Chatziralli, et al.
Published: (2018-09-01)

The Influence of Ionizing Radiation, Temperature, and Light on Eplerenone in the Solid State
by: Katarzyna Dettlaff, et al.
Published: (2014-01-01)

Eplerenone suppresses aldosterone/ salt-induced expression of NOX-4
by: Mohamed A Bayorh, et al.
Published: (2011-09-01)

Antagonists of mineralocorticoid receptors in the treatment of patients with post-infarced heart failure: the role of eplerenon
by: Vasily V. Kashtalap, et al.
Published: (2019-01-01)

Positive effect of eplerenone treatment on endothelial progenitor cells in patients with chronic heart failure
by: Christian Jung, et al.
Published: (2012-09-01)

The Effects of Eplerenone on the Circadian Blood Pressure Pattern and Left Ventricular Hypertrophy in Patients with Obstructive Sleep Apnea and Resistant Hypertension—A Randomized, Controlled Trial
by: Beata Krasińska, et al.
Published: (2019-10-01)

Eplerenone versus placebo for chronic central serous chorioretinopathy: the VICI RCT
by: Andrew Lotery, et al.
Published: (2021-01-01)

Effect of polymers on in-vitro performance of eplerenone sustained release matrix tablets
by: Sunil Reddy, et al.
Published: (2012-01-01)

Potential Renoprotective Effects of Eplerenone and Captopril in L-Name-Treated Rats
by: Omnyah A. El-kharashi, et al.
Published: (2011-12-01)

Synthesis and Physicochemical Characterization of the Process-Related Impurities of Eplerenone, an Antihypertensive Drug
by: Iwona Dams, et al.
Published: (2017-08-01)

Beneficial Effect of Eplerenone on Cardiac Remodelling and Electrical Properties of the Failing Heart
by: Walmor C De Mello
Published: (2006-03-01)

Effects of spironolactone and eplerenone on left ventricular diastolic function and neurohumoral factors in patients with heart failure
by: N. A. Nuritdinov, et al.
Published: (2020-12-01)

Effective Ocular Delivery of Eplerenone Using Nanoengineered Lipid Carriers in Rabbit Model
by: Abdelhakeem E, et al.
Published: (2021-07-01)

Pharmacokinetic study of eplerenone in rats after long-term coadministration with buckwheat tea
by: Liang Zou, et al.
Published: (2016-04-01)

Eplerenone Implantation Improved Adipose Dysfunction Averting RAAS Activation and Cell Division
by: Andrea Vecchiola, et al.
Published: (2020-04-01)

Aldosteronantagonist vid hjärtsvikt -En jämförande litteraturstudie mellan spironolakton och eplerenon
by: Fröberg, Jeanette
Published: (2014)

Mineralocorticoid Receptor Antagonists Eplerenone and Spironolactone Modify Adrenal Cortex Morphology and Physiology
by: Sofia S. Pereira, et al.
Published: (2021-04-01)

Development and validation of RP-HPLC method for estimation of eplerenone in spiked human plasma
by: Paraag Gide, et al.
Published: (2012-10-01)

A pilot study of the effects of eplerenone add-on therapy in patients taking renin–angiotensin system blockers
by: Noritaka Kawada, et al.
Published: (2015-06-01)

Characteristics of Japanese elderly patients with pulmonary arterial hypertension
by: Yukiko Takahashi, et al.
Published: (2020-09-01)

Clinical and economic burdens experienced by patients with painful diabetic peripheral neuropathy: An observational study using a Japanese claims database.
by: Nozomi Ebata-Kogure, et al.
Published: (2017-01-01)